DEA News:

The Drug Enforcement Administration (DEA) and U.S. Food and Drug Administration (FDA) issued a joint letter today, updating the public on the ongoing prescription stimulant shortages impacting patients across the United States and actions to resolve these shortages. 

The DEA and FDA are committed to working together on this issue and providing up-to-date information to the public. 

They will continue to do all they can to prevent stimulant drug shortages, limit their impact, and resolve them as quickly as possible.

To view the letter, visit DEA.gov.